Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TLR2 | O60603 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15218951 | 0.80 | HTT (0.35) | USP2TLR2HTT | |
| SCHEMBL11548915 | 0.76 | — | — | |
| SCHEMBL20324212 | 0.74 | ALDH1A1 (0.35) | USP2HTT | |
| SCHEMBL21664500 | 0.74 | ALDH1A1 (0.35) | USP2HTT | |
| SCHEMBL9005599 | 0.74 | — | — | |
| SCHEMBL3918933 | 0.73 | HTT (0.47) | USP2TLR2HTT | |
| SCHEMBL21664740 | 0.73 | PLA2G2A (0.35) | USP2HTT | |
| SCHEMBL20329993 | 0.73 | PLA2G2A (0.35) | USP2HTT | |
| SCHEMBL22224049 | 0.72 | LPAR3 (0.33) | USP2HTT | |
| SCHEMBL26986840 | 0.72 | DNM1 (0.38) | USP2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130225859-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225859-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | SOAT2, SOAT1, SGMS1 | USP2 1908/4885TLR2 274/4885HTT 1625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.